Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator

ObjectivePrognostic nutritional index (PNI), calculated as serum albumin (ALB) (g/L) + 5 × total lymphocyte count (109/L), is initially used to evaluate nutritional status in patients undergoing surgery and may evaluate the therapeutic effects and predict the survival of various solid tumors. The pr...

Full description

Bibliographic Details
Main Authors:	Li Chen, Ping Bai, Xiangyi Kong, Shaolong Huang, Zhongzhao Wang, Xiangyu Wang, Yi Fang, Jing Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Cell and Developmental Biology
Subjects:	prognostic nutritional index breast cancer neoadjuvant chemotherapy survival biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fcell.2021.656741/full

Similar Items

Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer
by: Takaaki Oba, et al.
Published: (2020-02-01)

Nutritional Risk Index Predicts Survival in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
by: Li Chen, et al.
Published: (2022-01-01)

Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study
by: Meijuan Xiang, et al.
Published: (2022-10-01)

Pretreatment Systemic Inflammation Response Index in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
by: Chen L, et al.
Published: (2020-03-01)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
by: Ziping Wu, et al.
Published: (2019-03-01)

Response to neoadjuvant chemotherapy and survival of children and adolescents with high-grade osteosarcoma treated based on the EURAMOS-1 protocol
by: Amaranto Suárez-Mattos, et al.
Published: (2022-01-01)

Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
by: Marta Truffi, et al.
Published: (2022-10-01)

Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival
by: Gilles Houvenaeghel, et al.
Published: (2024-02-01)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
by: Ruo-Xi Wang, et al.
Published: (2018-09-01)

The prognostic effect of residual tumor for advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy or primary debulking surgery
by: Shi‐Ping Yang, et al.
Published: (2022-07-01)

The Value of Prognostic Nutritional Index (PNI) in Predicting Survival and Guiding Radiotherapy of Patients With T1-2N1 Breast Cancer
by: Xin Hua, et al.
Published: (2020-01-01)

Systemic immune–inflammation index as a useful prognostic indicator predicts survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy
by: Chen L, et al.
Published: (2017-12-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)

Pathologic and immunohistochemical prognostic markers in residual triple-negative breast cancer after neoadjuvant chemotherapy
by: Silvia Mihaela Ilie, et al.
Published: (2024-01-01)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
by: Xuejun Gan, et al.
Published: (2023-03-01)

Neoadjuvant chemotherapy for treatment patients with rectal cancer with adverse prognostic factors: A review
by: Aleksey A. Nevolskikh, et al.
Published: (2022-11-01)

Postoperative Adjuvant Chemotherapy Improved the Prognosis in Locally Advanced Cervical Cancer Patients With Optimal Response to Neoadjuvant Chemotherapy
by: Xiaojie Feng, et al.
Published: (2020-12-01)

Prognostic Value of Plasma Epstein-Barr Virus DNA Levels Pre- and Post-Neoadjuvant Chemotherapy in Patients With Nasopharyngeal Carcinoma
by: Lisheng Zhu, et al.
Published: (2021-09-01)

Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients
by: Suzuki E, et al.
Published: (2023-06-01)

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
by: Jian-Wei Xie, et al.
Published: (2021-07-01)

Prospective Assessment of Systemic MicroRNAs as Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
by: Andrew McGuire, et al.
Published: (2020-07-01)

The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes
by: Lucie Laot, et al.
Published: (2021-01-01)

Identification of Ferroptosis-Related Prognostic Signature and Subtypes Related to the Immune Microenvironment for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
by: Yuhao Xu, et al.
Published: (2022-05-01)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
by: Chen Zheng, et al.
Published: (2023-10-01)

The Immunoscore in Localized Urothelial Carcinoma Treated with Neoadjuvant Chemotherapy: Clinical Significance for Pathologic Responses and Overall Survival
by: Elise F. Nassif, et al.
Published: (2021-01-01)

The role of neoadjuvant chemotherapy in the management of locally advanced cervix cancer: a systematic review
by: Mohammed Osman
Published: (2014-09-01)

Neoadjuvant chemotherapy improves survival rate in advanced urothelial carcinoma
by: Chia-Chun Tsai, et al.
Published: (2013-04-01)

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
by: Ileana Corbeau, et al.
Published: (2020-09-01)

The use of neoadjuvant chemotherapy in advanced endometrial cancer
by: L. Philp, et al.
Published: (2021-05-01)

Comparison of responses to neoadjuvant and adjuvant chemotherapies in muscle-invasive bladder cancer
by: Serhat Sekmek, et al.
Published: (2023-11-01)

Prognostic and clinicopathological effect of the prognostic nutritional index (PNI) in patients with cervical cancer: a meta-analysis
by: Zheng Niu, et al.
Published: (2023-12-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

Expression of aldehyde dehydrogenase after neoadjuvant chemotherapy is associated with expression of hypoxia-inducible factors 1 and 2 alpha and predicts prognosis in locally advanced breast cancer
by: Daniel Guimarães Tiezzi, et al.
Published: (2013-05-01)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
by: Fei Ji, et al.
Published: (2021-10-01)

Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy
by: Hong Yu, et al.
Published: (2022-09-01)

Prediction study of prognostic nutrition index on the quality of life of patients with cervical cancer undergoing radiotherapy and chemotherapy
by: Ying Chen, et al.
Published: (2023-05-01)

Prognostic Nutritional Index (PNI) as a Predictor in Patients with Metabolic Syndrome and Heart Failure
by: Zhang X, et al.
Published: (2023-08-01)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
by: Weiming Han, et al.
Published: (2022-11-01)